Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Allogenic Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients (Clinical Trial)

NCT04499105 is registered in ClinicalTrials.gov with Ahmad Jabir Rahyussalim as lead sponsor.

NCT NCT04499105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04499105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Allogenic Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients (Clinical Trial)
Lead sponsor
Ahmad Jabir Rahyussalim
Phase
Phase 2
Overall status
Unknown status
Start date
July 24, 2017
Completion date
December 31, 2020
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, disc degeneration, low back pain